Nathaniel Jablecki
Family Medicine · Arden, NCNPI 1598979312
Payments from drug & device makers
Across 82 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$233
- Novo Nordisk$231
- Abbott$137
- Amgen$122
- Lilly USA, LLC$107
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$88
- plus $500 from 20 others
What the payments were for
- Food & beverage$1,418100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $233 |
| Novo Nordisk | 15 | $231 |
| Abbott | 6 | $137 |
| Amgen | 8 | $122 |
| Lilly USA, LLC | 6 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| GSK | 2 | $48 |
| Novartis | 2 | $44 |
| Johnson & Johnson | 3 | $42 |
| Pfizer | 2 | $37 |
| Nevro Corp. | 2 | $36 |
| Eisai Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $20 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $5 |
How this compares
$1,418 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $93,114 |
| OzempicSemaglutide | 59 | $79,741 |
| JardianceEmpagliflozin | 57 | $61,244 |
| RybelsusSemaglutide | 16 | $35,919 |
| XareltoRivaroxaban | 30 | $35,607 |
| MounjaroTirzepatide | 28 | $29,669 |
| MyrbetriqMirabegron | 28 | $24,929 |
| JanuviaSitagliptin Phosphate | 22 | $21,068 |
| LinzessLinaclotide | 25 | $20,217 |
| Spiriva HandihalerTiotropium Bromide | 19 | $13,901 |
| FarxigaDapagliflozin Propanediol | 16 | $13,136 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,740 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $11,871 |
| Spiriva RespimatTiotropium Bromide | 14 | $10,277 |
| ProzacFluoxetine Hcl | 13 | $5,905 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $231 | $115,66075 claims |
| PfizerEliquis, Paxlovid | $37 | $94,54393 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $12 | $71,52171 claims |
| Johnson & JohnsonXarelto | $42 | $35,60730 claims |
| Lilly USA, LLCMounjaro | $107 | $29,66928 claims |
| AbbVieLinzess, Synthroid | $233 | $25,14388 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $24,92928 claims |
| AstraZenecaFarxiga, Nexium | $16 | $16,86229 claims |
| GSKTrelegy Ellipta | $48 | $12,74020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Arden
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.